Skip to main
PATH

UiPath (PATH) Stock Forecast & Price Target

UiPath (PATH) Analyst Ratings

Based on 15 analyst ratings
Hold
Strong Buy 13%
Buy 0%
Hold 80%
Sell 7%
Strong Sell 0%

Bulls say

UiPath is well-positioned to benefit from the growing demand for automation technologies across industries. Their end-to-end platform and partnerships with companies such as Deloitte and Accenture demonstrate their strong potential for growth. Additionally, their recent acquisition of WorkFusion and focus on vertical expertise in industries such as healthcare and financial services show promising opportunities for the company. With a large and expanding TAM and strong execution, UiPath's positive outlook is well-supported.

Bears say

UiPath is a market leader in the rapidly growing field of robotic process automation (RPA) and has a broad range of automation technologies that cater to industries across the board. Despite its strong financial performance in FY26, with ARR, net new ARR, and total revenue all exceeding expectations, the company's sector and geographical exposure may pose a risk, as its reliance on the Americas and Life Sciences and Financial Services industries may potentially lead to slower growth or volatility in revenue. Additionally, while the company is investing in AI and agent orchestration, it remains to be seen how successful these initiatives will be monetized, especially given the competitive market for orchestration tools.

UiPath (PATH) has been analyzed by 15 analysts, with a consensus rating of Hold. 13% of analysts recommend a Strong Buy, 0% recommend Buy, 80% suggest Holding, 7% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of UiPath and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About UiPath (PATH) Forecast

Analysts have given UiPath (PATH) a Hold based on their latest research and market trends.

According to 15 analysts, UiPath (PATH) has a Hold consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.27, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.27, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

UiPath (PATH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.